Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2015 April;81(4) > Minerva Anestesiologica 2015 April;81(4):405-18



Per citare questo articolo


Rivista di Anestesia, Rianimazione, Terapia Antalgica e Terapia Intensiva

Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623




Minerva Anestesiologica 2015 April;81(4):405-18


lingua: Inglese

Bloodstream infections in ICU with increased resistance: epidemiology and outcomes

Dimopoulos G. 1, Koulenti D. 1, 2, Tabah A. 2-4, Poulakou G. 5, Vesin A. 6, 7, Arvaniti K. 8, Lathyris D. 9, Matthaiou D. K. 1, Armaganidis A. 1, Timsit J. F. 4, 6, 7

1 Critical Care Department, Attikon University Hospital, Medical School, University of Athens, Athens, Greece; 2 Burns, Trauma, and Critical Care Research Centre, University of Queensland, Brisbane, Australia; 3 Department of Intensive Care Medicine, Royal Brisbane and Women’s Hospital, Brisbane, Australia; 4 Medical ICU, Albert Michallon University Hospital, Grenoble, France; 5 Fourth Department of Internal Medicine, Attikon University Hospital, Medical School, University of Athens, Athens, Greece; 6 Université Grenoble 1, U 823, Albert Bonniot Institute; Team 11: Outcome of mechanically ventilated patients and respiratory cancers, Grenoble, France; 7 Outcomerea Organization, Paris, France; 8 Critical Care Department, General Hospital “Papageorghiou”, Thessaloniki, Greece; 9 Critical Care Department, General Hospital “G. Gennimatas”, Thessaloniki, Greece


BACKGROUND: Aim of this study was to evaluate the epidemiology and outcomes of hospital-acquired bloodstream infections (HA-BSI) in Greek intensive care units (ICU).
METHODS: Secondary analysis of data from 29 ICU collected during the EUROBACT study, a large prospective, observational, multination survey of HA-BSI. First episodes of HA-BSI acquired in the ICU or within 48 hours prior to admission were recorded.
RESULTS: Gram-negative bacteria predominated namely Acinetobacter sp, Klebsiella sp, Pseudomonas sp (73.3% of monomicrobial infections) followed by Gram-positive cocci (18.3%); fungi (7.6%) and anaerobes (0.8%). Overall 73.3% of isolates were multidrug resistant (MDR), 47.1% extensively resistant (XDR) and 1.2% pan-drug resistant (PDR). Carbapenems were the most frequent empirically prescribed antibiotics, while colistin was the most frequently adequate; for both, calculated mean total daily doses were suboptimal. Overall 28-day all-cause mortality was 33.3%. In the multivariate analysis, factors adversely affecting outcome were higher SOFA score at HA-BSI onset (OR 1.19; 95% CI 1.08-1.31, P=0.0006), need for renal supportive therapy (OR 2.75; 95% CI 1.35-5.59, P=0.0053), and for vasopressors/inotropes (OR 2.68; CI 1.18-6.12, P=0.02); adequate empirical treatment had a protective effect (OR 0.48; CI 0.24-0.95, P=0.03).
CONCLUSION: TIMELY administration of adequately dosed treatment regimens and early ICU admission of critically ill patients could help in improving outcomes.

inizio pagina

Publication History

Per citare questo articolo

Dimopoulos G, Koulenti D, Tabah A, Poulakou G, Vesin A, Arvaniti K, et al. Bloodstream infections in ICU with increased resistance: epidemiology and outcomes. Minerva Anestesiol 2015 April;81(4):405-18. 

Corresponding author e-mail